HTGC earnings

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), will conduct its 2026 Annual Meeting of Stockholders by virtual meeting on Thursday, June 18, 2026 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was filed on April 23, 2026 and mailed to stockholders of record as of April 9, 2026. 2026 Annual Meeting of Stockholders June 18, 2026 at 9:00 a.m. Eastern Time Virtual Meeting via Internet: http://www.virtualshareholdermeeting.com/HTGC2026 Matters to be voted on include: 1) election of an independent director, 2) an advisory vote to approve the Company's named executive officer compensation, 3) an advisory vote on the frequency of the adv

Record Q1 2026 Total New Debt and Equity Commitments of $1.81 Billion, an Increase of 77.8% Year-over-Year Q1 2026 Total Fundings of $706.4 Million, an Increase of 31.0% Year-over-Year Record Q1 2026 Total Investment Income of $141.5 Million, an Increase of 18.4% Year-over-Year Q1 2026 Net Investment Income "NII" of $88.1 Million, an Increase of 13.8% Year-over-Year Q1 2026 NII of $0.48 per Share provides 120% Coverage of the Base Cash Distribution Closed Institutional Notes Offering of $300.0 Million of 5.350% Unsecured Notes due 2029 Conservative Balance Sheet Management with Net GAAP Leverage of 113.5% and Net Regulatory Leverage of 97.8%(1) Inclusive of the Adviser Funds A

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2026 financial results conference call for Tuesday, May 5, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our

Record Full-Year 2025 Total New Debt and Equity Commitments of $3.92 Billion, an Increase of 45.7% Year-over-Year Record Full-Year 2025 Total Fundings of $2.28 Billion, an Increase of 25.9% Year-over-Year Record Full-Year 2025 Total Investment Income of $532.5 Million, an Increase of 7.9% Year-over-Year Record Full-Year 2025 Net Investment Income "NII" of $341.7 Million, an Increase of 4.9% Year-over-Year Record Q4 2025 Total Gross Debt and Equity Commitments of $1.06 Billion, an Increase of 70.8% Year-over-Year Q4 2025 NII of $0.48 per Share provides 120% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net Leverage of 101.8% and Net Regulatory

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2025 financial results conference call for Thursday, February 12, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Re

Q3 2025 Total New Debt and Equity Commitments of $846.2 Million Record Q3 2025 Total Fundings of $504.6 Million Record Year-to-Date Ending Q3 2025 Total Debt and Equity Commitments of $2.87 Billion Record Year-to-Date Ending Q3 2025 Total Fundings of $1.75 Billion Record Q3 2025 Total Investment Income of $138.1 Million Q3 2025 Net Investment Income "NII" of $88.6 Million Q3 2025 NII of $0.49 per Share provides 122% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Leverage of 98.2% and Net Regulatory Leverage of 82.3%(1) Inclusive of the Adviser Funds Advised by Hercules Adviser LLC, its Wholly-owned Subsidiary, Hercules had over $1.

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2025 financial results conference call for Thursday, October 30, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section

CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

CARY, N.C., Aug. 8, 2025 Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with Hercules Capital, Inc. (NYSE:HTGC), due in 2030, which provides $110.0 million in committed capital at closing and an additional $40.0 million in two $20.0 million tranches available upon achievement of certain milestones, to be drawn at the Company's discretion;An exc

Q2 2025 Total Gross Debt and Equity Commitments of $1.0 Billion Record Q2 2025 Total Gross Fundings of $709.1 Million Record 1H 2025 Total Gross Debt and Equity Commitments of $2.02 Billion Record 1H 2025 Total Gross Fundings of $1.25 Billion Record Q2 2025 Net Investment Income "NII" of $88.7 Million Q2 2025 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Closed Upsized Offering of $350.0 Million of 6.000% Unsecured Notes due 2030 Renewed and Increased Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 95.0% and Net Regulatory Leverage of 78.7%(1) Inclusive of the Adviser F

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2025 financial results conference call for Thursday, July 31, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our website at inves

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in hidradenitis suppurativa (HS), psoriatic Arthritis (PsA) and adolescent HS, as well as Phase 2 studies in palmoplantar pustulosis (PPP) and axial spondyloarthritis (axSpA)Announced completion of enrollment of patients in the Phase 3 program in HS (the VELA program) and disclosed baseline characteristics, replicating the Phase 2 MIRA trialPresented an interim readout of the Phase 2 LEDA study in PPP, highlighting the potential of sonelokimab

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), will conduct its 2025 Annual Meeting of Stockholders by virtual meeting on Wednesday, June 18, 2025 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was filed on April 24, 2025 and mailed to stockholders of record as of April 17, 2025. 2025 Annual Meeting of Stockholders June 18, 2025 at 9:00 a.m. Eastern Time Virtual Meeting via Internet: http://www.virtualshareholdermeeting.com/HTGC2025 Matters to be voted on include: 1) election of three directors, 2) an advisory vote on the compensation of the Company's named executive officers, 3) authorization of the Company to sell or issue shares of its common stock

Q1 2025 Total Gross Debt and Equity Commitments of $1.02 Billion Q1 2025 Total Gross Fundings of $539.1 Million Q1 2025 Total Investment Income of $119.5 Million Q1 2025 Net Investment Income "NII" of $77.5 Million, or $0.45 per Share Q1 2025 NII of $0.45 per Share, provides 113% Coverage of the Base Cash Distribution Received an Investment Grade Rating Upgrade to BBB (high) from Morningstar DBRS Closed Offering of $287.5 Million of 4.750% Convertible Unsecured Notes due 2028 Conservative Balance Sheet Management with Net GAAP Leverage of 97.4% and Net Regulatory Leverage of 82.7%(1) Inclusive of the Adviser Funds Advised by Hercules Adviser LLC, its Wholly-Owned Subsidiary, Hercule

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2025 financial results conference call for Thursday, May 1, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the c

Record Full-Year 2024 Total Investment Income of $493.6 Million, an Increase of 7.1% Year-over-Year Record Full-Year 2024 Net Investment Income "NII" of $325.8 Million, an Increase of 7.2% Year-over-Year Record Full-Year 2024 Gross Fundings of $1.81 Billion, an Increase of 13.0% Year-over-Year Q4 2024 NII of $81.1 Million, or $0.49 per Share, provides 123% Coverage of the Base Cash Distribution Q4 2024 Total Gross Debt and Equity Commitments of $619.5 Million Q4 2024 Total Gross Fundings of $468.5 Million Conservative Balance Sheet Management with Net GAAP Leverage of 83.9% and Net Regulatory Leverage of 69.9% Inclusive of the Adviser Funds Managed by Hercules Adviser LLC, its

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2024 financial results conference call for Thursday, February 13, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can b

Record Q3 2024 Total Investment Income of $125.2 Million, an Increase of 7.3% Year-over-Year Q3 2024 Net Investment Income "NII" of $83.2 Million, or $0.51 per Share, an Increase of 8.3% Year-over-Year Q3 2024 NII Provides 128% Coverage of the Base Cash Distribution Q3 2024 Total Gross Debt and Equity Commitments of $430.7 Million Q3 2024 Total Gross Fundings of $272.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 92.5% and Net Regulatory Leverage of 83.0% Undistributed Earnings Spillover of $152.1 Million, or $0.94(1) per Ending Shares Outstanding Approximately $4.6 Billion of Assets Under Management, an Increase of 10.9% Year-over-Year(2) Hercules Capital

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2024 financial results conference call for Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access

Q2 2024 Total Gross Debt and Equity Commitments of $686.5 Million Record Q2 2024 Total Gross Fundings of $461.5 Million, an Increase of 28.7% Year-over-Year Record Q2 2024 Total Investment Income of $125.0 Million, an Increase of 7.5% Year-over-Year Q2 2024 Net Investment Income "NII" of $82.4 Million, or $0.51 per Share, an Increase of 8.8% Year-over-Year Q2 2024 NII Provides 128% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Leverage of 93.3% and Net Regulatory Leverage of 83.9% Undistributed Earnings Spillover of $145.0 Million, or $0.89(1) per Ending Shares Outstanding Approximately $4.6 Billion of Assets Under Management, an In

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2024 financial results conference call for Thursday, August 1, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), will conduct its 2024 Annual Meeting of Stockholders by virtual meeting on Thursday, June 20, 2024 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was filed on April 23, 2024 and mailed to stockholders of record as of April 19, 2024. 2024 Annual Meeting of Stockholders June 20, 2024 at 9:00 a.m. Pacific Time Virtual Meeting via Internet: www.virtualshareholdermeeting.com/HTGC2024 Matters to be voted on include: 1) election of three independent directors, 2) an advisory vote on the compensation of the Company's named executive officers, 3) authorization of the Company to sell or issue shares of its common

Record Q1 2024 Total Gross Debt and Equity Commitments of $956.0 Million, an Increase of 81.7% Year-over-Year Record Q1 2024 Total Gross Fundings of $605.2 Million, an Increase of 27.1% Year-over-Year Q1 2024 Total Investment Income of $121.6 Million, an Increase of 15.7% Year-over-Year Q1 2024 Net Investment Income "NII" of $79.2 Million, or $0.50 per Share, an Increase of 20.9% Year-over-Year Q1 2024 NII Provides 125% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Leverage of 91.0% and Net Regulatory Leverage of 81.7% Undistributed Earnings Spillover of $142.7 Million, or $0.88(1) per Ending Shares Outstanding Approximately $4.5 Bi

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2024 financial results conference call for Thursday, May 2, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the

Record Q4 2023 Total Investment Income of $122.6 Million, an Increase of 22.4% Year-over-Year Record Q4 2023 Net Investment Income "NII" of $86.0 Million, or $0.56 per Share, an Increase of 38.5% Year-over-Year Record Full-Year 2023 Total Investment Income of $460.7 Million, an Increase of 43.2% Year-over-Year Record Full-Year 2023 Net Investment Income "NII" of $304.0 Million, an Increase of 61.7% Year-over-Year Record Full-Year 2023 Total Gross Fundings of $1.6 billion, an Increase of 9.1% Year-over Year Inclusive of the Adviser Funds Managed by Hercules Adviser LLC, its Wholly-owned Subsidiary, Hercules had over $1.0 Billion of Available Liquidity as of Year End Q4 2023 NII P

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2023 financial results conference call for Thursday, February 15, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can b

Record Q3 2023 Total Investment Income of $116.7 Million, an Increase of 38.6% Year-over-Year Record Q3 2023 Net Investment Income "NII" of $76.8 Million, or $0.52 per Share, an Increase of 53.6% Year-over-Year Record Year-to-Date ending Q3 2023 Total Gross Fundings of $1.29 billion, an Increase of 17.7% Year-over Year Q3 2023 NII Provides 130% Coverage of the Base Cash Distribution Undistributed Earnings Spillover of $155.7 Million, or $1.03(1) per Ending Shares Outstanding Approximately $4.1 Billion of Assets Under Management, an Increase of 19.4% Year-over-Year(2) Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing pro

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2023 financial results conference call for Thursday, November 2, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access

Record Q2 2023 Total Investment Income of $116.2 Million, an Increase of 61.2% Year-over-Year Record Q2 2023 Net Investment Income "NII" of $75.7 Million, or $0.53 per Share, an Increase of 88.6% Year-over-Year Record 1H 2023 Total Gross Fundings of $834.8 million, an Increase of 5.6% Year-over Year Increased the Company's Base Cash Distribution to $0.40 per Share Q2 2023 NII Provides 132% Coverage of the New Base Cash Distribution Undistributed Earnings Spillover of $148.1 Million, or $1.02(1) per Ending Shares Outstanding Approximately $4.0 Billion of Assets Under Management, an Increase of 19.5% Year-over-Year(2) Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Compan

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2023 financial results conference call for Thursday, August 3, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), will conduct its 2023 Annual Meeting of Stockholders by virtual meeting on Thursday, June 22, 2023 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about May 10, 2023 to shareholders of record as of April 21, 2023. 2023 Annual Meeting of Stockholders June 22, 2023 at 9:00 a.m. Pacific Time Virtual Meeting via Internet: www.virtualshareholdermeeting.com/HTGC2023 Matters to be voted on include: 1) election of two independent directors, 2) an advisory vote on the compensation of the Company's named executive officers, 3) an advisory vote on the frequency of the advisory vote on exe

Record Q1 2023 Total Gross Fundings of $476.2 Million Record Q1 2023 Total Investment Income of $105.1 Million, an Increase of 61.3% Year-over-Year Record Q1 2023 Net Investment Income "NII" of $65.5 Million, or $0.48 per Share, an Increase of 83.0% Year-over-Year Q1 2023 NII Provides 123% Coverage of the Base Cash Distribution Inclusive of the Adviser Funds Managed by Hercules Adviser LLC, its Wholly-owned Subsidiary, Hercules had Approximately $1.0 Billion of Available Liquidity as of Quarter End Undistributed Earnings Spillover of $133.6 Million, or $0.96(1) per Ending Shares Outstanding Hercules Adviser LLC Established a New Institutional Private Credit Lending Program Ove

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2023 financial results conference call for Thursday, May 4, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the

Record Full-Year 2022 Total Gross Debt and Equity Commitments of $3.12 Billion Full-Year 2022 Total Gross Fundings of $1.47 Billion Record Full-Year 2022 Net Debt Portfolio Growth of $598.5 Million Record Full-Year 2022 Total Investment Income of $321.7 million, an Increase of 14.5% Year-over-Year Record Full-Year 2022 Net Investment Income "NII" of $188.1 million, an Increase of 25.4% Year-over-Year Record Q4 2022 Total Investment Income of $100.2 million, an increase of 38.3% Year-over-Year and Record Q4 2022 NII of $62.1 million, or $0.47 per Share, an Increase of 54.0% Year-over-Year Increased the Company's Base Cash Distribution to $0.39 per Share Q4 2022 NII Provides 121% Cover

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2022 financial results conference call for Thursday, February 16, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be

Record Year-to-Date Q3 2022 Total Gross Debt and Equity Commitments of $2.48 Billion Record Year-to-Date Q3 2022 Total Gross Fundings of $1.10 Billion Record Q3 2022 Total Gross Debt and Equity Commitments of $817.2 Million Record Year-to-Date Q3 2022 Net Debt Portfolio Growth of $465.1 Million Record Total Investment Income of $84.2 million, an increase of 20.0% year-over-year Q3 2022 Net Investment Income of $0.39 per Share Provides 108% Coverage of the Recently Increased Base Distribution Payout Increased the Company's Base Cash Distribution to $0.36 per Share Undistributed Earnings Spillover of $134.1 Million, or $1.03 per Ending Shares Outstanding Hercules Capital, Inc. (NYSE:H

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2022 financial results conference call for Wednesday, November 2, 2022, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access

-- Clinical programs continue to progress, with initial data from Phase 2 study of "off the shelf" SLATE-KRAS and multiple studies within T cell-enhanced SARS-CoV-2 program (CORAL) expected this year -- -- Follow up data from subset of CORAL-BOOST study shows strong neutralizing antibody titers persisted without decay for at least 6 months after single boost administration of self-amplifying mRNA (samRNA) -- -- New credit facility provides financial flexibility entering period of multiple potential milestones -- -- Cash, cash equivalents, marketable securities and restricted cash of $159.2 million as of June 30, 2022 -- -- Gritstone will host a conference call today, August 4 at 4:30 p.m

Record 1H 2022 Total Gross Debt and Equity Commitments of $1.66 Billion Record 1H 2022 Gross Fundings of $790.7 Million Record 1H 2022 Net Debt Investment Portfolio Growth of $359.8 Million Record Q2 Total Gross Debt and Equity Commitments of $1.04 Billion Increased the Company's Quarterly Base Cash Distribution to $0.35 per Share Increased Available Liquidity to over $775 Million Through a Series of Capital Markets Transactions Undistributed Earnings Spillover of $150.5 Million, or $1.18 per Ending Shares Outstanding Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established sta

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2022 financial results conference call for Thursday, July 28, 2022, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access th

FDA lifted clinical hold on IND for CP101Enrollment in PRISM4 Phase 3 trial of CP101 in recurrent CDI expected to proceed in H2 2022$15 million drawn from new $55 million term debt facility Anticipated cash runway into Q2 2024Corporate update call today at 8am ET SOMERVILLE, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. ("Finch" or "Finch Therapeutics") (NASDAQ:FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today provided a corporate update and reported financial results for the first quarter ended March 31, 2022. "Finch made several important

MAESTRO-NAFLD-1 late-breaker and three other Madrigal abstracts accepted for oral presentation at the EASL International Liver Congress™Data from the Phase 3 MAESTRO-NAFLD-1 study continue to reinforce the safety and efficacy profiles of resmetiromMadrigal remains on track to disclose topline data from MAESTRO-NASH in the fourth quarter and anticipates filing for accelerated approval under Subpart H next yearPlanned MAESTRO-NASH Outcomes trial, a non-invasive Phase 3 study designed to accelerate the full approval timeline for non-cirrhotic NASH, will evaluate resmetirom effects on liver decompensation events in patients with early NASH cirrhosis Madrigal enters into term loan facility with a

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), will conduct its 2022 Annual Meeting of Stockholders by virtual meeting on Thursday, June 23, 2022 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about May 4, 2022 to shareholders of record as of April 25, 2022. 2022 Annual Meeting of Stockholders June 23, 2022 at 9:00 a.m. Pacific Time Virtual Meeting via Internet: www.virtualshareholdermeeting.com/HTGC2022 Matters to be voted on include: 1) election of two directors, 2) an advisory vote on the compensation of the Company's named executive officers, and 3) ratification of the Company's independent public accounting firm. Abou

Record Quarterly Net Debt Portfolio Growth of $190.7 Million Record Q1 Total Gross Debt and Equity Commitments of $615.2 Million Q1 Total Gross Fundings of $351.6 Million Undistributed Earnings Spillover of $171.7 Million, or $1.39 per Ending Shares Outstanding Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31, 2022. The earnings release can be accessed at Hercules' Investor Relations website a

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2022 financial results conference call for Thursday, May 5, 2022, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To listen to the call, please dial (877) 304-8957 (or (408) 427-3709 internationally) and reference Conference ID: 6863888 if asked, approximately 10 minutes prior to the start of the call. A t

Record Annual Total Gross Debt and Equity Commitments of $2.64 Billion, an Increase of 122.1% Year-over-Year Record Annual Total Gross Fundings of $1.57 Billion, an Increase of 106.0% Year-over-Year Record Q4 Total Gross Debt and Equity Commitments of $947.8 Million Record Q4 Total Gross Fundings of $503.3 Million Q4 2021 Net Investment Income of $0.35 per Share Provides 106% Coverage of Base Distribution Payout Record Undistributed Earnings Spillover of $192.1 Million, or $1.65 per Ending Shares Outstanding Declared a New $0.60 Supplemental Distribution Payable Equally over Four Quarters beginning with the Q4 2021 Distribution Paid in March 2022 Hercules Capital, Inc. (NYSE:HTGC) ("

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2021 financial results conference call for Tuesday, February 22, 2022, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To listen to the call, please dial (877) 304-8957 (or (408) 427-3709 internationally) and reference Conference ID: 1780603 if asked, approximately 10 minutes prior to the st

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2021 financial results conference call for Thursday, October 28, 2021, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To listen to the call, please dial (877) 304-8957 (or (408) 427-3709 internationally) and reference Conference ID: 9145314 if asked, approximately 10 minutes prior to the start of the call